Pfizer LLN 100 Pill - purple oval, 17mm
Generic Name: lorlatinib
Pill with imprint Pfizer LLN 100 is Purple, Oval and has been identified as Lorbrena 100 mg. It is supplied by Pfizer Inc.
Lorbrena is used in the treatment of Non-Small Cell Lung Cancer and belongs to the drug class multikinase inhibitors. Lorbrena 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer LLN 100
Lorbrena
- Generic Name
- lorlatinib
- Imprint
- Pfizer LLN 100
- Strength
- 100 mg
- Color
- Purple
- Size
- 17.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0231
More about Lorbrena (lorlatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.